An Introduction to Forensic Toxicology

Size: px
Start display at page:

Download "An Introduction to Forensic Toxicology"

Transcription

1 An Introduction to Forensic Toxicology Jennifer Shea, PhD, FCACB Ken Obenson, MBBS MFFLM (UK) FRCPC (Anat) FRCPC (Forensic Path) Dip American Brd of Path (Anat & Clin/Cytopath/Forensic Path) April 11, 2015

2 What is forensic toxicology? Sample collection What testing is done? Volatile Screen Broad Spectrum Drug Screen Targeted Drug Testing Biochemical Analysis Interpreting Results General Considerations Outline

3 Toxicology is the study of the adverse effects of drugs and chemicals on biological systems Forensic toxicology is the application of toxicology for the purposes of the law Four disciplines: 1. Postmortem Toxicology 2. Human Performance Toxicology 3. Doping Control 4. Workplace Drug Testing What is Forensic Toxicology?

4 Work with coroners and pathologists to help establish the role of alcohol, drugs, and poisons in the cause of death Identify and quantify the presence of drugs and chemicals in blood and other specimens Provide advice regarding result interpretation Drug kinetics and interactions Metabolism Drug tolerance Postmortem artifacts Drug stability Postmortem Toxicology

5 For every case, pathologists should collect: Preserved blood Vitreous humor Urine (if available) Other tissues are sometimes useful depending on the nature of the case and what specimens from the list above are available: Liver Bile Stomach Contents Sample Collection: The Basics

6 Whole Blood Two FULL preserved (grey top) vacutainers (minimum 10 ml required) Preservative (NaF) prevents bacterial activity that may cause postmortem alcohol formation Preservative prevents degradation of drugs (eg cocaine) by enzymes in blood Vacutainers should be full to prevent loss of volatile substances (eg. alcohol) to air space above sample Blood obtained from the femoral vein is preferred due to the potential for postmortem drug redistribution if collected from other sites Blood should be kept at 4 C (up to one week) until sent to the toxicology laboratory Sample Collection: The Basics

7 Postmortem Drug Redistribution (PMR) Property of chemical make up of drug, volume of distribution, etc Some drugs are sequestered in tissues; very little freely circulates in blood After death, significant amounts of drug can be released from tissues (eg heart, liver, lungs) which falsely elevates blood concentration in vessels associated with these organs Tricyclic antidepressants are the classic example of drugs undergoing PMR however many reports of other drugs as well PMR may be related to the postmortem interval as well Sample Collection: The Basics

8 Postmortem Drug Redistribution: Case Reports Anatomic Location Femoral /Subclavian Time of Collection At scene Autopsy* Blood Fentanyl Concentration Case 1: 19 ng/ml Case 2: 18 ng/ml Case 1: 15 ng/ml Case 2: 39 ng/ml Heart Autopsy* Case 1: 22 ng/ml (Ratio = 1.5) Case 2: 46 ng/ml (Ratio = 1.2) Adapted from J Forensic Sci. 2014;59(5): *Autopsy occurred on average 18.8 hours after blood draw at scene. Sample Collection: The Basics

9 Urine Two preservative free (red top) vacutainers. Preserved vacutainers also acceptable. Urine may be used as a screening tool when required. Drugs/metabolites typically present in higher concentrations and remain for days after use Vitreous Humour Preservative free vacutainer. Preserved vacutainer also acceptable except when requesting electrolytes Sodium in preservative interferes with Na result Sample Collection: The Basics

10 Liver Tissue Preservative free plastic specimen container. Minimum 10 grams required. Most drugs metabolized in liver. May be useful when blood unavailable. Bile Fluid Preservative free vacutainer or plastic specimen container. Gastric contents Preservative free vacutainer or plastic specimen container. Note: Minimal data available to interpret drug concentrations in these specimen types (esp. stomach contents and bile fluid). Consult with toxicologist if testing is required. Sample Collection: Additional Specimens

11 In general, perform three different screens: 1. Alcohol analysis 2. Broad spectrum drug screen 3. Biochemical analyses (aids in identification of diabetes, kidney disease, diabetic/alcoholic ketoacidosis, etc) *Targeted drug testing available upon request (for most drugs) What type of testing is done?

12 Specimen Tests Routinely Performed Volatile screen (ethanol, methanol, isopropanol, acetone) BLOOD HbA1c (marker of diabetes) Broad Spectrum Drug Screen (includes amphetamines, anticonvulsants, antidepressants, antihistamines, antipsychotics, barbiturates, benzodiazepines, cannabinoids, CNS stimulants, cocaine and metabolites, hallucinogens, hypnosedatives, hypoglycemics, muscle relaxants, NSAIDs, opiates/opiods, salicylates) What type of testing is done?

13 Specimen VITREOUS HUMOR Tests Routinely Performed Volatile screen (ethanol, methanol, isopropanol, acetone) Glucose (marker of diabetes) Beta-hydroxybutyrate (marker of ketoacidosis) URINE OTHER (liver, bile, stomach contents, etc) Urea and creatinine (marker of kidney function) Used for screening purposes when required. Screen includes the same list of drugs as blood. Not routinely tested unless required for interpretation. When testing of a specific drug or group of drugs in these specimens is required, please contact the toxicologist to discuss. What type of testing is done?

14 Screens and (if present) quantitates four volatile substances using head space GC-FID analysis 1. Ethanol One of the most commonly abused drugs 2. Methanol Common solvent used in industrial and clinical labs 3. Acetone Ketone body produced during carbohydrate deprivation (eg. alcoholic/diabetic ketoacidosis) 4. Isopropanol Rubbing alcohol. May also be produced by acetone metabolism. Toxicology Testing: Volatile Screen

15 Death due to ethanol ingestion may be the result of: Acute ingestion Alcoholic ketoacidosis Ethanol in combination with other drugs Consumption of large amounts of ethanol results in respiratory and CNS depression in a dose-dependent manner < 50 mg/dl generally considered insignificant > mg/dl may result in coma >350 mg/dl possible death from respiratory arrest These thresholds are general guidelines. Limits may be lowered when other drugs are present. Toxicology Testing: Ethanol

16 Caveats associated with interpreting ethanol concentrations: 1. Postmortem Formation Up to 100 mg/dl ethanol (and even higher in some case reports) can be formed in blood due to fermentation of substrates (eg. glucose) in the presence of bacteria (eg. decomposed body). Ethanol also measured in vitreous humor or urine; protected fluid therefore more resistant to postmortem ethanol formation If ethanol present in blood but not vitreous, suspect postmortem formation 2. Tolerance Dispositional/Metabolic Altered absorption, distribution or elimination due to repeated ethanol use Cellular Altered pharmacological response to ethanol Toxicology Testing: Ethanol

17 Screen performed on all blood samples received using immunoassay and mass spectrometry (LC/TOF-MS) All positive results are confirmed and quantitated using a variety of analytical techniques (GC-MS, GC-MS/MS, LC-MS/MS) > 300 drugs included in screen If you want to know if a particular drug is included, call the toxicologist. Commonly encountered drugs include opiates/opioids (codeine, morphine, methadone, fentanyl), antidepessants, stimulants (cocaine, amphetamine/methamphetamine), other therapeutic medications Toxicology Testing: Broad Spectrum Drug Screen

18 Next to alcohol, most common postmortem tox finding Opiate = Naturally occuring alkaloid analgesic (eg. morphine and codeine) Opioid = Opiates + synthetic and semi-synthetic alkaloids whose pharmacological effects mimic morphine (eg. heroin, fentanyl, methadone, etc) Morphine Codeine Heroin Fentanyl Methadone Toxicology Testing: Opiates/Opioids

19 Opiates/opioids elicit their effects by binding to opioid receptors within the central and peripheral nervous system as well as GI tract Therapeutic Effects: Mainly used for pain relief (acute and chronic) Side Effects: CNS and respiratory depression, sedation, euphoria, constipation, nausea/vomiting, euphoria Additive effects with alcohol on CNS and respiratory depression Codeine < Morphine/Methadone < Heroin << Fentanyl Toxicology Testing: Opiates/Opioids

20 Tolerance is very important to consider when interpreting opioid results Best demonstrated by looking at therapeutic, toxic, and fatal ranges for methadone Therapeutic (ng/ml) In 16 drug related fatalities, mean postmortem methadone concentration was 700 ng/ml (range 110 1,310 ng/ml) In 35 non-drug related deaths, the mean postmortem methadone concentration was 640 ng/ml (range 100 4,260 ng/ml) It is almost impossible to interpret methadone results without usage history Toxicology Testing: Opiates/Opioids Toxic (ng/ml) Fatal (ng/ml) Approx Approx Approx. >300

21 Benzodiazepines (eg. diazepam, clonazepam, etc) One of the most widely prescribed drugs CNS depressants anxiolytics, anticonvulsants, muscle relaxants Rarely result in fatality unless combined with other drugs Cannabinoids Delta-9 THC is primary active metabolite Metabolites may be present in urine for many days (up to 20 days in chronic smokers) Diazepam Delta-9 THC Toxicology Testing: Other common drugs

22 Stimulants (eg. cocaine, amphetamine, methamphetamine) Not as commonly observed in postmortem cases in NB Concomitant use of alcohol and cocaine can result in production of a toxic metabolite, cocaethylene Antidepressants (eg. amitriptyline, sertraline, venlafaxine, citalopram, etc) Very common to detect antidepressant(s) on postmortem toxicology, either as incidental finding or related to an overdose Most subject to PMR interpret with caution if central blood used for analysis Cocaine Amitriptyline Toxicology Testing: Other common drugs

23 No single analytical technique can detect all drugs Not all drugs are part of broad spectrum drug screen Targeted drug testing can be done for some newer drugs (eg. bath salts, synthetic cannabinoids) or those less frequently encountered (eg. poisons such as CO) Important to provide case history with all toxicology requests! Methodology used depends largely on the drug s chemical structure. GC-MS, GC-MS/MS, LC-MS/MS, etc Toxicology Testing: Targeted Drug Testing

24 Laboratory also performs routine biochemical analyses on specimens as an adjunct to toxicology testing Vitreous humor is best specimen for most biochemical testing as blood is usually hemolysed which may interfere with analytical methodologies Exception: HbA1c in whole blood Biochemical testing aids in identification of undiagnosed or poorly controlled diabetes (VH glucose, WB HbA1c), diabetic ketoacidosis (VH β-oh, glucose) and kidney function (VH creatinine, urea) Toxicology Testing: Biochemical Analyses

25 Diabetes is a disease characterized by hyperglycemia Complications are classified as chronic (nephropathy, retinopathy, neuropathy) and acute (diabetic ketoacidosis) Estimated that 1 million have the disease but do not know it Biochemical Analyses: Diabetes Public Health Agency of Canada, 2011 Canadian Diabetes Association

26 Insufficient cellular glucose to maintain energy stores Adipose tissue breaks down fatty acids Liver converts fatty acids to ketone bodies as alternative energy source: Beta-hydroxybutyrate Acetoacetate Acetone Liver also breaks down glycogen into glucose END RESULT: DKA GLUCOSE and KETONE BODIES ph (metabolic acidosis)

27 Extremely difficult to interpret post-mortem blood glucose Continuous consumption of glucose by surviving cells and bacteria post-mortem Glucose almost always undetectable in blood Blood glucose rarely measured in forensic chemistry Vitreous humor is better preserved after death making it a better specimen choice High VH glucose suggestive of high plasma glucose at time of death Caveats with VH glucose testing: Ongoing metabolism occurs in VH too so will also see drop postmortem Low VH glucose Hypoglycemia Biochemical Analyses: Blood vs Vitreous Humor Glucose

28 β-hydroxybutyrate (βhb) Ketone body produced during ketoacidosis Measured in vitreous humor Can help elucidate chronic hyperglycemia from acute diabetic ketoacidosis (>3 mmol/l generally indicative of ketoacidosis) HbA1c Formed through non-enzymatic addition of glucose to N-terminal valine of β chain of Hb Marker of longer term (~3 mth) glycemic control Reflects metabolic state of the deceased in the weeks prior to death More stable than glucose in blood (internal studies show stability up to 6 mth) Can support other findings including elevated glucose and βhb HbA1c 6.5% consistent with diabetes Biochemical Analyses: Other Markers of Diabetes

29 Evidence of drug overdose or non-compliance with prescribed medication? State of body on discovery Decomposition may result in decreased (stability) or increased (PMR) drug levels Postmortem formation of ethanol Source of blood (central vs peripheral)? Tolerance to drugs detected in blood? Opiates/opioids Ethanol Interpreting Results: General Considerations

30 Forensic toxicology can aid pathologists and coroners in elucidating the cause and manner of death Proper specimen collection is vital to obtaining meaningful toxicology results Preserved vacutainers help maintain specimen integrity of blood samples Peripheral (femoral) blood is always preferred over a central source A case history (including medication summary) and/or preliminary autopsy findings can greatly aid the toxicologist Can aid with interpretation of drug levels where tolerance is important Can help determine need for additional testing above and beyond general drug screen When in doubt, call the toxicologist! Summary

31 Please contact me with any questions. Phone: Thank you!

What Can Dead People Tell Us? Postmortem Toxicology for Attorneys

What Can Dead People Tell Us? Postmortem Toxicology for Attorneys What Can Dead People Tell Us? Postmortem Toxicology for Attorneys Dr. Allison A. Muller Diplomate, American Board of Applied Toxicology Principal/Owner: Acri Muller Consulting, LLC Learning objectives

More information

Pain Management Drug Testing: A Laboratory Perspective

Pain Management Drug Testing: A Laboratory Perspective Ernest Jimenez III, M.T.(ASCP) Nothing to declare. Laboratory manager at Pharos Diagnostics, LLC., located in Tucson, AZ. Pain Management Drug Testing: A Laboratory Perspective 1 2 Pain Management Drug

More information

St. Louis University Forensic Toxicology Laboratory

St. Louis University Forensic Toxicology Laboratory St. Louis University Forensic Toxicology Laboratory Specimen Collection Guidelines Postmortem Forensic Toxicology Sample Collection Guidelines Scope The provides comprehensive analysis of general unknowns

More information

All substances are poisons: there is none which is not a poison. The right dose differentiates a poison and a remedy. (Paraclesus, )

All substances are poisons: there is none which is not a poison. The right dose differentiates a poison and a remedy. (Paraclesus, ) All substances are poisons: there is none which is not a poison. The right dose differentiates a poison and a remedy (Paraclesus, 1493-1541) Discussion Questions About Paraclesus Quote 1. Do you agree

More information

Urine Drug Testing. Methadone/Buprenorphine 101 Workshop. Ron Joe, MD, DABAM December 10, 2016

Urine Drug Testing. Methadone/Buprenorphine 101 Workshop. Ron Joe, MD, DABAM December 10, 2016 Urine Drug Testing Methadone/Buprenorphine 101 Workshop Ron Joe, MD, DABAM December 10, 2016 Learning objectives Clarify the purpose of urine drug testing (UDT) Distinguish between UDT for detection of

More information

Effective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature)

Effective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature) 1 Policy #: 803 (PLH-803-02) Effective Date: NA Reviewed Date: 4/11/2008 Subject: URINE DRUG SCREENS Approved by: Laboratory Executive Director, Ed Hughes (electronic signature) Approved by: Laboratory

More information

Learning Objectives. Drug Testing 10/17/2012. Utilization of the urine drug screen: The good, the bad, and the ugly

Learning Objectives. Drug Testing 10/17/2012. Utilization of the urine drug screen: The good, the bad, and the ugly Utilization of the urine drug screen: The good, the bad, and the ugly Jennifer A. Lowry, MD Chief, Section of Medical Toxicology Children s Mercy Hospital Kansas City, MO Learning Objectives Describe the

More information

Introduction to Postmortem Studies in Forensic Pathology

Introduction to Postmortem Studies in Forensic Pathology Introduction to Postmortem Studies in Forensic Pathology Objectives Compare and contrast a forensic autopsy versus a medical autopsy. Describe different types of evidentiary specimen collection in forensic

More information

FORENSIC TOXICOLOGY SERVICE

FORENSIC TOXICOLOGY SERVICE Accredited Medical Laboratory, Reference No: 0814 FORENSIC TOXICOLOGY SERVICE LEICESTER ROYAL INFIRMARY USER HANDBOOK 2016-17 1 of 12 CONTENTS Contacts and normal laboratory hours 3 Our services 4 Specimen

More information

Lyndsey Knoy, D-ABFT-FT Forensic Scientist Washington State Toxicology Laboratory.

Lyndsey Knoy, D-ABFT-FT Forensic Scientist Washington State Toxicology Laboratory. Lyndsey Knoy, D-ABFT-FT Forensic Scientist Washington State Toxicology Laboratory Lyndsey.Knoy@wsp.wa.gov Forensic Toxicology is an interdisciplinary science that analyzes blood, fluid and/or tissues for

More information

Cross-reactivity reactivity in EMIT

Cross-reactivity reactivity in EMIT Blood Drug Analysis at the State Bureau of Investigation Crime Laboratory Richard W. Waggoner, Jr. Sample Requirements 2-10 ml gray top vacutainers At least 10 ml of urine sample for drug facilitated sexual

More information

Bell-Ringer. Forensic Science

Bell-Ringer. Forensic Science Bell-Ringer Forensic Science Looking for Toxins Forensic Toxicology Part 2 Toxins Most poisons don t cause visible changes to the body neither in a living person nor during an autopsy. Some do, but most

More information

Testing for Controlled Substances

Testing for Controlled Substances Testing for illicit drugs Testing for Controlled Substances 1 Purposes: Employment Sports Screening medical eval. Legal Monitoring Treatment Probation Prescribing controlled substances Forensics 2 Drug

More information

Laboratory Testing to Support Pain Management: Methods, Concepts and Case Studies

Laboratory Testing to Support Pain Management: Methods, Concepts and Case Studies Laboratory Testing to Support Pain Management: Methods, Concepts and Case Studies Frederick G. Strathmann, PhD, DABCC, (CC,TC) Medical Director, Toxicology Associate Scientific Director of MS ARUP Laboratories

More information

Drug Profiles of Apprehended Drivers in Victoria

Drug Profiles of Apprehended Drivers in Victoria Drug Profiles of Apprehended Drivers in Victoria J Gerostamoulos, P McCaffrey, O H. Drummer and M Odell*. Victorian Institute of Forensic Medicine, Department of Forensic Medicine, Monash University, 57-83

More information

EDUCATIONAL COMMENTARY rd TEST EVENT Chemistry Urine Drug Testing

EDUCATIONAL COMMENTARY rd TEST EVENT Chemistry Urine Drug Testing EDUCATIONAL COMMENTARY 2003 3 rd TEST EVENT Chemistry Urine Drug Testing Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE

More information

Cutoff levels for hydrocodone in a blood test

Cutoff levels for hydrocodone in a blood test Cutoff levels for hydrocodone in a blood test The premier DNA and drug testing company in the North Texas area. Specializing in legal cases but also provide testing for employers and private individuals.

More information

Forensic Toxicology Scope of Testing and Detection Limits

Forensic Toxicology Scope of Testing and Detection Limits Forensic Toxicology Scope of Testing and Detection Limits Table of Contents QUALITATIVE ANALYSES... 2 Volatile Screen by GC/FID... 2 Carbon Monoxide by Microdiffusion... 2 Ethylene Glycol by GC/MS... 2

More information

Alcohol. Ethanol Highlands Parkway, Suite 100 Smyrna, GA 30082

Alcohol. Ethanol Highlands Parkway, Suite 100 Smyrna, GA 30082 Alcohol The alcohol of interest is ethanol. Ethanol has a sedative effect in the brain. Ethanol intoxication symptoms include blurred vision, slurred speech, poor coordination and difficulty thinking depending

More information

Procedure for Toxicology Analysis Version 7 Toxicology Unit Effective Date: 03/14/2014 Issued by Drug Chemistry Forensic Scientist Manager

Procedure for Toxicology Analysis Version 7 Toxicology Unit Effective Date: 03/14/2014 Issued by Drug Chemistry Forensic Scientist Manager Toxicology Analysis 1.0 Purpose - This procedure specifies the required elements for analyzing toxicology submissions and reporting drug testing results. 2.0 Scope This procedure applies to all submissions

More information

3/8/2018. Reasons for Doing UDT. UDT: A Tool in Risk Assessment. Faculty/Presenter Disclosure. Urine Drug Testing in Chronic Pain Management

3/8/2018. Reasons for Doing UDT. UDT: A Tool in Risk Assessment. Faculty/Presenter Disclosure. Urine Drug Testing in Chronic Pain Management Urine Drug Testing in Chronic Pain Management March 8, 2018 Faculty/Presenter Disclosure Faculty: Andrew J Smith, MDCM Relationships with commercial interests: None to report Andrew J Smith, MDCM Staff

More information

Procedure for Toxicology Analysis Version 4 Toxicology Unit Effective Date: 05/10/2013. Toxicology Analysis

Procedure for Toxicology Analysis Version 4 Toxicology Unit Effective Date: 05/10/2013. Toxicology Analysis Toxicology Analysis 1.0 Purpose - This procedure specifies the required elements for analyzing toxicology submissions and reporting the results of the analysis. 2.0 Scope This procedure applies to all

More information

Guidelines on Autopsy Practice: Scenario 3: Suspected illicit drugs

Guidelines on Autopsy Practice: Scenario 3: Suspected illicit drugs Guidelines on Autopsy Practice: Scenario 3: Suspected illicit drugs Updates made August 2005 1. Pathology encountered: causes of death re-ordered, with addition of chronic alcohol ketoalcoholic syndrome

More information

A substance that reduces pain and may or may not have psychoactive properties.

A substance that reduces pain and may or may not have psychoactive properties. GLOSSARY OF TERMS AMPHETAMINE-TYPE STIMULANTS (ATS) A group of substances, mostly synthetic, with closely related chemical structure which have, to varying degrees, a stimulating effect on the central

More information

ADMINISTRATION OF JUSTICE FORENSIC TOXICOLOGY

ADMINISTRATION OF JUSTICE FORENSIC TOXICOLOGY I. INTRODUCTION ADMINISTRATION OF JUSTICE FORENSIC TOXICOLOGY A. Toxicology is concerned with the chemical and physical properties of toxic substances, their physiological effects on living organisms and

More information

Urine Drug Testing to Monitor Opioid Use In Managing Chronic Pain

Urine Drug Testing to Monitor Opioid Use In Managing Chronic Pain Faculty Disclosure Henry C. Nipper, PhD, DABCC Dr. Nipper has listed no financial interest/arrangement that would be considered a conflict of interest. Urine Drug Testing to Monitor Opioid Use In Managing

More information

Drug Overdose Fatality Surveillance System (DOFSS) 2015 Annual Report

Drug Overdose Fatality Surveillance System (DOFSS) 2015 Annual Report Drug Overdose Fatality Surveillance System (DOFSS) 05 Annual Report Released: October 07 Sarah L. Hargrove, MS Patrick J. Ward, MPH Terry L. Bunn, PhD Kentucky Injury Prevention and Research Center, bona

More information

The Drug Evaluation and Classification Program

The Drug Evaluation and Classification Program The Drug Evaluation and Classification Program International Association of Chiefs of Police Drug Evaluation and Classification (DEC) Program The Drug Evaluation and Classification (DEC) Program is a transportation

More information

Overview of the AACC Academy s LMPG: Using clinical laboratory tests to monitor drug therapy in pain management patients

Overview of the AACC Academy s LMPG: Using clinical laboratory tests to monitor drug therapy in pain management patients Overview of the AACC Academy s LMPG: Using clinical laboratory tests to monitor drug therapy in pain management patients Gwen McMillin, PhD, DABCC(CC,TC) Professor, University of Utah Medical Director,

More information

Urine Drug Testing Methods 3-5

Urine Drug Testing Methods 3-5 Urine Drug Testing Methods 3-5 Type of Test Logistics Pearls Initial Screening Test: Immunoassay Confirmatory Test: Gas chromatography-mass spectrometry (GCMS) + or Liquid chromatography-mass spectrometry

More information

Test Definition: PCDSO Pain Clinic Drug Screen, Urine

Test Definition: PCDSO Pain Clinic Drug Screen, Urine Reporting Title: Pain Clinic Drug Screen, U Performing Location: Rochester Specimen Requirements: Collection Container/Tube: Plastic urine container Submission Container/Tube: Plastic, 60-mL urine bottle

More information

Toxicology aspects of SUDI. Dr Stephen Morley STH

Toxicology aspects of SUDI. Dr Stephen Morley STH Toxicology aspects of SUDI Dr Stephen Morley STH Epidemiology of SUDI toxicology Neonatal-placental transfer Breast milk 3 rd person administration Association between illicit drug use in pregnancy and

More information

NARCOTIC NOTES FLIPBOOK BY: PER:

NARCOTIC NOTES FLIPBOOK BY: PER: NARCOTIC NOTES FLIPBOOK BY: PER: 1 https://www.youtube. com/watch?v=lolb21bii-a 2 Laws, Collection, & Preservation Narcotic Drugs = natural or synthetic substance that produces bodily (physiological) or

More information

Gold Standard for Urine Drug Testin Urine Drug Testing Why U rine? Urine?

Gold Standard for Urine Drug Testin Urine Drug Testing Why U rine? Urine? Gold Standard for Urine Drug Testing Developed by TRMC Pain Management Center Jill Duffy, RN,BC Pam Kennell, RN, BC Heidi Beisch, RN Urine Drug Testing A DIAGNOSTIC tool For an OBJECTIVE test Based on

More information

BLOOD SCIENCES DEPARTMENT OF CLINICAL BIOCHEMISTRY. 2. Sample collection and requesting procedure for toxicology analysis

BLOOD SCIENCES DEPARTMENT OF CLINICAL BIOCHEMISTRY. 2. Sample collection and requesting procedure for toxicology analysis Authoriser: Peter Beresford Page 1 of 5 For the most up-to-date version of this document please view the online version at: https://www.nbt.nhs.uk/severn-pathology/pathology-services/clinical-biochemistry/toxicology

More information

Payment Policy: Urine Specimen Validity Testing Reference Number: CC.PP.056 Product Types: ALL Effective Date: 11/01/2017 Last Review Date:

Payment Policy: Urine Specimen Validity Testing Reference Number: CC.PP.056 Product Types: ALL Effective Date: 11/01/2017 Last Review Date: Payment Policy: Reference Number: CC.PP.056 Product Types: ALL Effective Date: 11/01/2017 Last Review Date: Coding Implications Revision Log See Important Reminder at the end of this policy for important

More information

INVOLVEMENT OF DRUGS IN ACCIDENT CAUSATION

INVOLVEMENT OF DRUGS IN ACCIDENT CAUSATION INVOLVEMENT OF DRUGS IN ACCIDENT CAUSATION Jim GEROSTAMOULOS, Helen BATZIRIS, Olaf H. DRUMMER Victorian Institute of Forensic Medicine and Department of Forensic Medicine, Monash University, Southbank,

More information

Drug Screening: Things You Need to Know

Drug Screening: Things You Need to Know Drug Screening: Things You Need to Know (a view inside the clinical laboratory) Gary L. Horowitz, MD Director, Clinical Chemistry, Beth Israel Deaconess Medical Center Associate Professor of Pathology,

More information

Forensic Toxicology. William C. Bress, PhD State Toxicologist Adjunct Assistant Professor Department of Biology University of Vermont

Forensic Toxicology. William C. Bress, PhD State Toxicologist Adjunct Assistant Professor Department of Biology University of Vermont Forensic Toxicology William C. Bress, PhD State Toxicologist Adjunct Assistant Professor Department of Biology University of Vermont History of Forensic Toxicology Paracelsus (1493-1541) 1541) Orfila (1787-1853)

More information

Jen L. Schroeder, B.S.

Jen L. Schroeder, B.S. PO Box 20590 Boulder, Colorado 80308 5375 Western Avenue Boulder, Colorado 80301 (303) 440-4500 Fax (303) 440-0668 www.chematox.com EDUCATION Jen L. Schroeder, B.S. Western Kentucky University, Bowling

More information

Test Definition: PDSOX Pain Clinic Drug Screen, Chain of Custody, Urine

Test Definition: PDSOX Pain Clinic Drug Screen, Chain of Custody, Urine Reporting Title: Pain Clinic Drug Screen, CoC, U Performing Location: Rochester Specimen Requirements: Container/Tube: Chain-of-Custody Kit (Supply T282) containing the specimen containers, seals, and

More information

National Drug-Related Deaths Index

National Drug-Related Deaths Index HRB Bulletin Drug Deaths 2015 National Drug-Related Deaths Index 2004 to 2015 data Overview This update presents figures from the National Drug- Related Deaths Index (NDRDI) on deaths due to poisoning

More information

ACUTE & CHRONIC ETHANOL EFFECTS An Overview

ACUTE & CHRONIC ETHANOL EFFECTS An Overview ACUTE & CHRONIC ETHANOL EFFECTS An Overview University of Papua New Guinea School of Medicine & Health Sciences, Division of Basic Medical Sciences Clinical Biochemistry: PBL Seminar MBBS Yr 4 VJ Temple

More information

Laboratory Service Report

Laboratory Service Report 4 05/25/19 Client C702884-DLP ROCHESTER Amphetamines, Confirmation Positive Confirmed POSITIVE by LC-S/S for the following: Amphetamine = 52 ethamphetamine = 124 ethamphetamine exists in the d- and l-isomeric

More information

Patient-Centered Urine Drug Testing. Douglas Gourlay, MD, MSc, FRCPC, FASAM

Patient-Centered Urine Drug Testing. Douglas Gourlay, MD, MSc, FRCPC, FASAM Patient-Centered Urine Drug Testing Douglas Gourlay, MD, MSc, FRCPC, FASAM Declaration of Potential Conflict of Interest The content of this presentation is non- commercial and does not represent any conflict

More information

UNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES Discipline of Biochemistry and Molecular Biology

UNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES Discipline of Biochemistry and Molecular Biology UNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES Discipline of Biochemistry and Molecular Biology 1 PBL SEMINAR ACUTE & CHRONIC ETHANOL EFFECTS An Overview Sites

More information

Frequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up

Frequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up Frequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up Dr. Bhushan M. Kapur Associate Professor Department of Laboratory Medicine and Pathobiology, Faculty

More information

Figure 1. National Drug Overdose Deaths Number Among All Ages, by Gender,

Figure 1. National Drug Overdose Deaths Number Among All Ages, by Gender, Figure 1. National Drug Overdose Deaths Number Among All Ages, by Gender, -217 1, Total Overdose Deaths Male Female 8, 7,237 6, 4, 16,849 2 21 22 23 24 36,1 25 26 27 28 29 21 211 212 213 214 215 216 217-217

More information

Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population

Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population Adam S. Ptolemy 1, Colleen Murray 2, Edward Dunn 3,

More information

MEDICAL POLICY Drug Testing

MEDICAL POLICY Drug Testing POLICY: PG0069 ORIGINAL EFFECTIVE: 01/01/11 LAST REVIEW: 11/13/18 MEDICAL POLICY Drug Testing GUIDELINES This policy does not certify benefits or authorization of benefits, which is designated by each

More information

EDUCATIONAL COMMENTARY METHADONE

EDUCATIONAL COMMENTARY METHADONE EDUCATIONAL COMMENTARY METHADONE Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits see the Continuing Education

More information

Schedule of Accreditation

Schedule of Accreditation Schedule of Accreditation Organisation Name Trading As INAB Reg No Contact Name Address Medical Bureau Of Road Safety 30T Helen Kearns Contact Phone No 01-7165555 Email Website Accreditation Standard Health

More information

September HCMC Toxicology Transition: Additional information and Frequently Asked Questions

September HCMC Toxicology Transition: Additional information and Frequently Asked Questions September 2016 HCMC Toxicology Transition: Additional information and Frequently Asked Questions Many clinicians have asked for more information about the Urine Drug Compliance Analysis (LAB8742) switch

More information

Detection of Drugs-of-Abuse by Tandem Mass Spectrometry.

Detection of Drugs-of-Abuse by Tandem Mass Spectrometry. Detection of Drugs-of-Abuse by Tandem Mass Spectrometry. Dr Tim Laurens MSc.Chem(Pretoria), Ph.D. Chem (Pretoria), MSc.Toxicology (Surrey,UK) FRSChem, MFSSoc Email: laurensj@lancet.co.za / tim.laurens@up.ac.za

More information

Conflict of Interest Disclosure

Conflict of Interest Disclosure Patient Rx Drug Misuse and Abuse: Compliance Toxicology Monitoring in Clinical Practice Toxicology Staff Andrea Terrell, Ph.D., DABCC Chief Scientific Officer George Behonick, Ph.D., DABFT, Manager, FBU

More information

The Drug Testing Process. Employer or Practice

The Drug Testing Process. Employer or Practice Disclosures Clinical Professor, Jefferson Medical College BOD MROCC [Medical Review Officer Certification Council] BOD National Sleep Foundation BOD POEMS [Pennsylvania Occupational & Environmental Medicine

More information

Tests that have had changes to the method/ CPT code, units of measurement, scope of analysis, reference comments, or specimen requirements.

Tests that have had changes to the method/ CPT code, units of measurement, scope of analysis, reference comments, or specimen requirements. In our continuing effort to provide you with the highest quality toxicology laboratory services available, we have compiled important changes regarding a number of tests we perform. Listed below are the

More information

WELCOME! 12/13/2018. Today s Topic: Urine Drug Screens in OUD Treatment UW PACC

WELCOME! 12/13/2018. Today s Topic: Urine Drug Screens in OUD Treatment UW PACC Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences 12/13/2018 WELCOME! Today s Topic: Urine Drug Screens in OUD Treatment Should I test and how should I do drug testing

More information

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative The SCE Narrative is written by the Sentinel Community Epidemiologist (SCE) and provides

More information

PAIN & ANALGESIA. often accompanied by clinical depression. fibromyalgia, chronic fatigue, etc. COX 1, COX 2, and COX 3 (a variant of COX 1)

PAIN & ANALGESIA. often accompanied by clinical depression. fibromyalgia, chronic fatigue, etc. COX 1, COX 2, and COX 3 (a variant of COX 1) Pain - subjective experience associated with detection of tissue damage ( nociception ) acute - serves as a warning chronic - nociception gone bad often accompanied by clinical depression fibromyalgia,

More information

FATAL POISONINGS BY MEDICINAL OPIOIDS IN FINLAND

FATAL POISONINGS BY MEDICINAL OPIOIDS IN FINLAND FATAL POISONINGS BY MEDICINAL OPIOIDS IN FINLAND ERKKI VUORI 12.-13.11.2012 HJELT INSTITUUTTI OIKEUSLÄÄKETIETEEN OSASTO FINLAND IS AN IDEAL COUNTRY FOR POST- MORTEM TOXICOLOGICAL INVESTIGATIONS High autopsy

More information

MEDICAL POLICY No R2 DRUG TESTING

MEDICAL POLICY No R2 DRUG TESTING Summary of Changes MEDICAL POLICY DRUG TESTING Effective Date: April 10, 2017 Review Dates: 5/15, 5/16, 11/16, 2/17 Date Of Origin: May 13, 2015 Status: Current Clarifications: Deletions: Additions: Pg.

More information

COUNTY OF SAN DIEGO. Opioid Update

COUNTY OF SAN DIEGO. Opioid Update COUNTY OF SAN DIEGO Opioid Update Linda Bridgeman Smith, DUI & Prevention Services Manager Health & Human Services Agency, Behavioral Health Services Co-chair, Prescription Drug Abuse Task Force 1 HEADLINES

More information

Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities

Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities Svetla Slavova, PhD Sara LaMantia, MS Terry Bunn, PhD Tracey Corey, MD 2016 Safe States Annual Meeting April 13, 2016, Albuquerque,

More information

Claire Gilbert, Tony Margetts, Gilda Nunez, Bryony Sedgwick, Tim Allison. Thanks to Hull Public Health, Prof. Marks and Paul Smith

Claire Gilbert, Tony Margetts, Gilda Nunez, Bryony Sedgwick, Tim Allison. Thanks to Hull Public Health, Prof. Marks and Paul Smith There is something in the heroin: responding to a rise in drug related deaths and the emergence of fentanyl and carfentanil in a local illicit drug market Claire Gilbert, Tony Margetts, Gilda Nunez, Bryony

More information

DRUG TESTING POLICY. Policy Number: ADMINISTRATIVE T0 Effective Date: October 1, Related Policies None

DRUG TESTING POLICY. Policy Number: ADMINISTRATIVE T0 Effective Date: October 1, Related Policies None DRUG TESTING POLICY UnitedHealthcare Oxford Reimbursement Policy Policy Number: ADMINISTRATIVE 259.1 T0 Effective Date: October 1, 2017 Table of Contents Page INSTRUCTIONS FOR USE... 1 APPLICABLE LINES

More information

B. To assess an individual when clinical evaluation suggests use of non-prescribed medications or illegal substances; or

B. To assess an individual when clinical evaluation suggests use of non-prescribed medications or illegal substances; or Integrated Reference #: MP/D010 Page: 1 of 7 PRODUCT APPLICATION: PreferredOne Community Health Plan (PCHP) PreferredOne Administrative Services, Inc. (PAS) ERISA PreferredOne Administrative Services,

More information

Controlled Substance Monitoring in the Age of the Opioid Epidemic

Controlled Substance Monitoring in the Age of the Opioid Epidemic Controlled Substance Monitoring in the Age of the Opioid Epidemic Paul E. Hilliard, MS, MD Hospital Pain Committee Chair Department of Anesthesiology CME housekeeping I have no financial disclosures AKA,

More information

Medical Affairs Policy

Medical Affairs Policy Medical Affairs Policy Service: Urine Drug/Alcohol Screening and Testing PUM 250-0013-1803 Medical Policy Committee Approval 03/06/18 Effective Date 07/01/18 Prior Authorization Needed No Disclaimer: This

More information

DRUG TESTING POLICY. Policy Number: ADMINISTRATIVE T0 Effective Date: March 1, Related Policies None

DRUG TESTING POLICY. Policy Number: ADMINISTRATIVE T0 Effective Date: March 1, Related Policies None DRUG TESTING POLICY UnitedHealthcare Oxford Reimbursement Policy Policy Number: ADMINISTRATIVE 259.3 T0 Effective Date: March 1, 2018 Table of Contents Page INSTRUCTIONS FOR USE... 1 APPLICABLE LINES OF

More information

MEDICAL POLICY Drug Testing

MEDICAL POLICY Drug Testing POLICY: PG0069 ORIGINAL EFFECTIVE: 01/01/11 LAST REVIEW: 04/10/18 MEDICAL POLICY Drug Testing GUIDELINES This policy does not certify benefits or authorization of benefits, which is designated by each

More information

Applications of High Resolution Mass Spectrometry in Forensic Toxicology. Patrick Kyle, PhD.

Applications of High Resolution Mass Spectrometry in Forensic Toxicology. Patrick Kyle, PhD. Applications of High Resolution Mass Spectrometry in Forensic Toxicology Patrick Kyle, PhD pkyle@umc.edu Financial Disclosures Grant/Research Support: None Salary/Consultant Fees: None Board/Committee/Advisory

More information

DRUG TESTING POLICY. Policy Number: ADMINISTRATIVE T0 Effective Date: January 1, Related Policies None

DRUG TESTING POLICY. Policy Number: ADMINISTRATIVE T0 Effective Date: January 1, Related Policies None DRUG TESTING POLICY UnitedHealthcare Oxford Reimbursement Policy Policy Number: ADMINISTRATIVE 259.2 T0 Effective Date: January 1, 2018 Table of Contents Page INSTRUCTIONS FOR USE... 1 APPLICABLE LINES

More information

Toxicology 101. Arizona Problem Solving Courts April 25, 2016

Toxicology 101. Arizona Problem Solving Courts April 25, 2016 Toxicology 101 Arizona Problem Solving Courts April 25, 2016 Aaron Brown, Ph.D. Technical Group Lead Norchem Drug Testing Laboratory Cordant Health Solutions Flagstaff, Arizona Toxicology Toxicology is

More information

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE CITY

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE CITY 2009 FINAL REPORT INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE CITY This report was prepared by: Dr. Jose Arbelaez, M.D. of Baltimore Substance Abuse Systems, and Ryan J. Petteway,

More information

Opioids: Use, Abuse and Cause of Death. Jennifer Harmon Assistant Director - Forensic Chemistry Orange County Crime Laboratory

Opioids: Use, Abuse and Cause of Death. Jennifer Harmon Assistant Director - Forensic Chemistry Orange County Crime Laboratory Opioids: Use, Abuse and Cause of Death Jennifer Harmon Assistant Director - Forensic Chemistry Orange County Crime Laboratory jharmon@occl.ocgov.com Opioid: Any psychoactive chemical that resembles morphine

More information

Test Name Results Units Bio. Ref. Interval

Test Name Results Units Bio. Ref. Interval 135091312 Age 30 Years Gender Male 15/9/2017 122400M 15/9/2017 11729M 19/9/2017 40644M Ref By Final Test Results Units Bio. Ref. Interval DRUGS OF ABUSE, URINE AMHETAMINE SCREEN, URINE results indicate

More information

Fastect II Drug Screen Dipstick Test Training and Certification Program

Fastect II Drug Screen Dipstick Test Training and Certification Program Fastect II Drug Screen Dipstick Test Training and Certification Program Fastect II Training Page 1 of 7 Rev. B Fastect II Drug Screen Dipstick Test Training and Certification for Test Administrators The

More information

Community Drug Early Warning System (CDEWS-3): Washington, DC - Site 3 of 4

Community Drug Early Warning System (CDEWS-3): Washington, DC - Site 3 of 4 Community Drug Early Warning System (CDEWS-3): Washington, DC - Site 3 of 4 Office of National Drug Control Policy Executive Office of the President May 2017 ACKNOWLEDGMENTS This report was funded by Cooperative

More information

Evaluation of the Impact of Expanding ELISA Screening in DUID Investigations. Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K.

Evaluation of the Impact of Expanding ELISA Screening in DUID Investigations. Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K. Evaluation of the Impact of Expanding ELISA Screening in DUID Investigations Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K. Logan FSF Emerging Forensic Scientist Award Oral Presentation Disclosure

More information

Drug Testing: How to Evaluate Results

Drug Testing: How to Evaluate Results Drug Testing: How to Evaluate Results Prepared for you by the West Virginia Drug Testing Laboratory Drug testing, whether for an individual or a large corporation, consists of two necessary steps - specimen

More information

Oxymorphone Distribution in Biological Matrices: A Collection of Case Studies

Oxymorphone Distribution in Biological Matrices: A Collection of Case Studies Oxymorphone Distribution in Biological Matrices: A Collection of Case Studies Brian Simons, Forensic Toxicologist Montgomery County Coroner s Office / Miami Valley Regional Crime Laboratory May 1, 2008

More information

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: SECOND QUARTER, 2008

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: SECOND QUARTER, 2008 INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: SECOND QUARTER, 28 A report from the Office of Epidemiology and Planning Baltimore City Health Department

More information

Welcome! Supreme Court of Ohio Specialized Dockets Conference. October 23-24, 2017

Welcome! Supreme Court of Ohio Specialized Dockets Conference. October 23-24, 2017 Welcome! Supreme Court of Ohio Specialized Dockets Conference October 23-24, 2017 Drug Testing: Do you know enough to be dangerous? Presented by William L. Parker President & CEO American Court & Drug

More information

Controlled Substance Monitoring and Drugs of Abuse Testing Determination

Controlled Substance Monitoring and Drugs of Abuse Testing Determination CPT s: 80305 Drug test(s), presumptive, any number of drug classes, any number of devices or procedures (eg, immunoassay); capable of being read by direct optical observation only (eg, dipsticks, cups,

More information

Rapid Spot Tests for Detecting the Presence of Adulterants in Urine Specimens Submitted for Drug Testing

Rapid Spot Tests for Detecting the Presence of Adulterants in Urine Specimens Submitted for Drug Testing Clinical Chemistry / SPOT TESTS TO DETECT ADULTERANTS IN URINE SPECIMENS Rapid Spot Tests for Detecting the Presence of Adulterants in Urine Specimens Submitted for Drug Testing Amitava Dasgupta, PhD,

More information

Fentanyl Postmortem Redistribution: Preliminary Findings Regarding the Relationship Among Femoral Blood and Liver and Heart Tissue Concentrations

Fentanyl Postmortem Redistribution: Preliminary Findings Regarding the Relationship Among Femoral Blood and Liver and Heart Tissue Concentrations Fentanyl Postmortem Redistribution: Preliminary Findings Regarding the Relationship Among Femoral Blood and Liver and Heart Tissue Concentrations Kristin Luckenbill 1,2, Jonathan Thompson 3, Owen Middleton

More information

Toxicological Investigation of Drug Impaired Driving Toxicology Laboratory Survey

Toxicological Investigation of Drug Impaired Driving Toxicology Laboratory Survey Toxicological Investigation of Drug Impaired Driving Toxicology Laboratory Survey Kayla J. Lowrie, MS, Jennifer Turri, BS, Jill Yeakel, MSFS, Barry K. Logan, PhD, DABFT, Arcadia University, 450 S. Easton

More information

Drug Testing Policy. Reimbursement Policy CMS Approved By. Policy Number. Annual Approval Date. Reimbursement Policy Oversight Committee

Drug Testing Policy. Reimbursement Policy CMS Approved By. Policy Number. Annual Approval Date. Reimbursement Policy Oversight Committee Reimbursement Policy CMS 1500 Drug Testing Policy Policy Number 2018R6005A Annual Approval Date 07/11/2018 Approved By Reimbursement Policy Oversight Committee IMPORTANT NOTE ABOUT THIS REIMBURSEMENT POLICY

More information

2017 Drug Screen Tests

2017 Drug Screen Tests 2017 Drug Screen Tests The ABCs of Applying the CMS 2017 HCPCS Codes Written by: Karen D. Chappell, EJD, MBA, CIRCC, CPMA, CPC-I, CHC Terminology Immunoassay Qualitative Therapeutic Quantitative GC/MS

More information

Dane County Oral Fluid Pilot Project- Establishing an Oral Fluid Drug Testing Program in Alabama

Dane County Oral Fluid Pilot Project- Establishing an Oral Fluid Drug Testing Program in Alabama Dane County Oral Fluid Pilot Project- Establishing an Oral Fluid Drug Testing Program in Alabama Curt Harper, Ph.D., F-ABFT Alabama Department of Forensic Sciences Candace Lightner, Founder and President

More information

Beating Drug Tests and Defending Positive Results

Beating Drug Tests and Defending Positive Results Beating Drug Tests and Defending Positive Results Amitava Dasgupta Beating Drug Tests and Defending Positive Results A Toxicologist s Perspective Amitava Dasgupta Department of Pathology and Laboratory

More information

Investigation of Propofol in Post- Mortem and Ante-Mortem Specimens by GC/MS

Investigation of Propofol in Post- Mortem and Ante-Mortem Specimens by GC/MS Investigation of Propofol in Post- Mortem and Ante-Mortem Specimens by GC/MS Mike Frontz, Robert Rodriguez, Gary Kunsman Bexar County Medical Examiner s Office, San Antonio, TX Brad Hall, Patricia Schroeder,

More information

Agonists: morphine, fentanyl Agonists-Antagonists: nalbuphine Antagonists: naloxone

Agonists: morphine, fentanyl Agonists-Antagonists: nalbuphine Antagonists: naloxone Opioid Definition All drugs, natural or synthetic, that bind to opiate receptors Agonists: morphine, fentanyl Agonists-Antagonists: nalbuphine Antagonists: naloxone Opioid agonists increase pain threshold

More information

Postmortem Redistribution of Fentanyl in Blood

Postmortem Redistribution of Fentanyl in Blood Clinical Chemistry / Postmortem Redistribution of Fentanyl Postmortem Redistribution of Fentanyl in Blood Kalen N. Olson, PhD, 1 Kristin Luckenbill, PhD, JD, 1 Jonathan Thompson, MD, 2 Owen Middleton,

More information

What is pregabalin? Pregabalin tablets. Pregabalin misuse. National Drug Treatment Centre Research. Administration

What is pregabalin? Pregabalin tablets. Pregabalin misuse. National Drug Treatment Centre Research. Administration What is pregabalin? Pregabalin is a prescription drug used to manage a number of long-term conditions, including epilepsy, neuropathic pain and generalised anxiety disorder. Similar to benzodiazepines,

More information

Option D: Drugs and Medicines. Workbook

Option D: Drugs and Medicines. Workbook IB Chemistry SL/HL Option D: Drugs and Medicines D1. Pharmaceutical products Workbook 1. List three effects that drugs or medicines have on the functioning of the body. a) b) c) 2. What is meant by natural

More information

Fluids. There are 32 body fluids that may be found at a crime scene

Fluids. There are 32 body fluids that may be found at a crime scene Fluids& Toxicology Fluids There are 32 body fluids that may be found at a crime scene Some of them include amniotic fluid, bile, cerebrospinal fluid, mucus, perspiration, phlegm, saliva, semen, tears,

More information

Pain Management and Compliance Toxicology. Greg Jellick, MSFS, D-ABFT-FT Technical Director Quality Toxicology San Antonio, TX

Pain Management and Compliance Toxicology. Greg Jellick, MSFS, D-ABFT-FT Technical Director Quality Toxicology San Antonio, TX Pain Management and Compliance Toxicology Greg Jellick, MSFS, D-ABFT-FT Technical Director Quality Toxicology San Antonio, TX Prescription Drug Abuse: A National Problem Prescription drug abuse is a growing

More information

The Utility of Urine Drug Screening

The Utility of Urine Drug Screening The Utility of Urine Drug Screening Treating Addiction, Saving Lives Sea Cruises Bye Tazmania, still far from New Zealand February 8 th, 2018 Mandy Manak, MD FASAM, ISAM, CSAM, MRO Medical Director, ICDO

More information